86 results
POS AM
PPBT
Purple Biotech Ltd
28 Mar 24
Prospectus update (post-effective amendment)
4:01pm
was obtained by fraud;
the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion
424B3
PPBT
Purple Biotech Ltd
14 Nov 23
Prospectus supplement
4:13pm
by fraud;
the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion of the Israeli
F-1/A
mx3m08 rud99qdyl05tm
13 Nov 23
Registration statement (foreign) (amended)
4:11pm
D
g8f8c0h3y q1ql0g
31 Oct 23
$5.43 mm in options / securities to be acquired, sold $5.43 mm, 1 investor
4:30pm
F-1
d4tbxiq8hrutiq
30 Oct 23
Registration statement (foreign)
4:30pm
6-K
EX-4.1
r8pp4gypqdlw4cc54 xq
19 Oct 23
Report of Foreign Private Issuer
10:36am
424B5
hjjbl22
19 Oct 23
Prospectus supplement for primary offering
10:27am
F-3/A
e37d0v70ix1hyqphs3sw
17 May 23
Shelf registration (foreign) (amended)
5:20pm
424B3
zm5ud4ddjq23i
5 Apr 23
Prospectus supplement
5:21pm
424B3
r26irtn0
3 Apr 23
Prospectus supplement
8:57am
F-3
u4f d16v4anjrpm
7 Dec 22
Shelf registration (foreign)
9:17pm
6-K
EX-1.1
4hlcj
9 Jun 21
Report of Foreign Private Issuer
5:06pm
424B5
hthcj0 gxq45l0yj
9 Jun 21
Prospectus supplement for primary offering
4:54pm